Kathryn Reed

QEP Resources, Inc. (NYSE:QEP): Updated Analyst Ratings

QEP Resources, Inc. (QEP) up 8.91 per cent in the past week, is under coverage of 17 analysts who collectively recommend a hold rating on stock. 11 of the analysts have a buy or better rating; the 0 sells versus 0 underperforms. The 16 equity analysts who rate the stock have an average target price at $21.56, with individual targets ranging between $13 and $29. The shares closed last trade at $20.29, implying that analysts see shares rising about 6.26 per cent in 12 months’ time.

Insider Activity: Insiders look pessimistic about the prospects of the company that they seem to offload shares while they are 51.42 up so far this year. A VP, GC, and Corp Secretary at QEP Resources, Inc. (QEP) sold shares in the company in a transaction completed on Tuesday March 08, 2016. Woosley Christopher K offloaded 1,717 shares in the company at an average price of $10.24 and ended up generating $17,580 in proceeds. Woosley Christopher K retains 87,790 shares in the company after this transaction. A VP and General Counsel in the company, Woosley Christopher K, on Thursday September 10, 2015 collected $2,080 from the sale of 158 shares at $10.24 each. Insiders are expected to know better about the health and prospects of their company, which is why insiders’ move deserves attention.

Earnings to Watch: Investors considering QEP stock at the going market price of $20.29/share should know the stock will next release quarterly results for the June 2016 quarter. For the reporting quarter, analysts expect the company to deliver -$0.39 in earnings per share (EPS). That would represent a -533.33% year-over-year decrease. Revenue for the same period is expected to arrive at $350.55M.

Earnings Roundup: In the last fiscal quarter alone, QEP Resources, Inc. generated around $261.3M in revenue and net income of -$0.53/share. That compares with the consensus estimate $369.58M and -$0.6/share, respectively. For the prior quarter revenue for the company hit $468.3M, with earnings at -$0.01/share.

Analyst Coverage: Raymond James has been a brokerage house following shares of QEP Resources, Inc. (QEP), so its rating change is noteworthy. The stock was upgraded to Strong Buy from Outperform, wrote analysts at Raymond James, in a note issued to clients on Friday April 29, 2016. There was another key note issued by JP Morgan on Tuesday April 12, 2016. The firm launched coverage on QEP at Overweight.

Price Momentum: Despite the 0.9% increase in value, the stock’s new closing price represents a 0.55% rise in value from company’s one year high of $20.47. The stock is currently holding below its 50 day moving average of $23.12 and above its 200 day moving average of $17.68. Over the last three months and over the last six months, the shares of QEP Resources, Inc. (QEP), have changed 46.29% and 13.78%, respectively.

 

Latest Hemispherx Biopharma, Inc. (NYSEMKT:HEB) Target Price Suggests Stock Is Worth $0.96/Share

Hemispherx Biopharma, Inc. (HEB) up 5.83 per cent in the past week, is under coverage of 0 analysts who collectively recommend a buy rating on stock. 0 of the analysts have a buy or better rating; the 0 sells versus 0 underperforms. The 1 equity analysts who rate the stock have an average target price at $0.96, with individual targets ranging between $0.96 and $0.96. The shares closed last trade at $0.13, implying that analysts see shares rising about 638.46 per cent in 12 months’ time.

Insider Activity: Insiders look optimistic about the prospects of the company that they seem to accumulate shares while they are 58.75 up so far this year. A CEO,Pres,Exec Vice Chairman at Hemispherx Biopharma, Inc. (HEB) purchased shares in the company in a transaction completed on Friday March 18, 2016. Equels Thomas K. accumulated 30,000 shares in the company at an average price of $0.13 and ended up spending $3,900 in the investment. Equels Thomas K. now have 1,484,548 shares in the company after this transaction. A CEO,Pres,Exec Vice Chairman in the company, Equels Thomas K., on Friday March 11, 2016 spent $6,400 from the purchase of 40,000 shares at $0.13 each. Insiders are expected to know better about the health and prospects of their company, which is why insiders’ move deserves attention.

Earnings Roundup: In the last fiscal quarter alone, Hemispherx Biopharma, Inc. generated around $50000 in revenue and net income of $Last 4 Weeks/share. That compares with the consensus estimate $50000 and $Last Week/share, respectively. For the prior quarter revenue for the company hit $40000, with earnings at -$0.03/share.

Analyst Coverage: Midtown Partners has been a brokerage house following shares of Hemispherx Biopharma, Inc. (HEB), so its rating change is noteworthy. The stock was initiated at Strong Buy, wrote analysts at Midtown Partners, in a note issued to clients on Thursday April 02, 2015. There was another key note issued by Chardan Capital Markets on Tuesday January 21, 2014. The firm launched coverage on HEB at Buy.

Price Momentum: Despite the 8.83% increase in value, the stock’s new closing price represents a -47.08% fall in value from company’s one year high of $0.23. The stock is currently holding above its 50 day moving average of $-0.22 and below its 200 day moving average of $0.13. Over the last three months and over the last six months, the shares of Hemispherx Biopharma, Inc. (HEB), have changed -3.87% and 0.12%, respectively.

 

Latest Platform Specialty Products Corporation (NYSE:PAH) Target Price Suggests Stock Is Worth $11.14/Share

Platform Specialty Products Corporation (PAH) up 13.49 per cent in the past week, is under coverage of 8 analysts who collectively recommend a hold rating on stock. 3 of the analysts have a buy or better rating; the 0 sells versus 0 underperforms. The 7 equity analysts who rate the stock have an average target price at $11.14, with individual targets ranging between $9 and $12. The shares closed last trade at $10.77, implying that analysts see shares rising about 3.44 per cent in 12 months’ time.

Insider Activity: Insiders look optimistic about the prospects of the company that they seem to accumulate shares while they are -16.06 down so far this year. A Corporate Treasurer at Platform Specialty Products Corporation (PAH) purchased shares in the company in a transaction completed on Thursday March 17, 2016. Jacoboski David A accumulated 1,000 shares in the company at an average price of $8.49 and ended up spending $8,490 in the investment. Jacoboski David A now have 3,302 shares in the company after this transaction. A Director in the company, Ashken Ian G H, on Wednesday December 09, 2015 spent $568,000 from the purchase of 50,000 shares at $8.49 each. Insiders are expected to know better about the health and prospects of their company, which is why insiders’ move deserves attention.

Earnings to Watch: Investors considering PAH stock at the going market price of $10.77/share should know the stock will next release quarterly results for the June 2016 quarter. For the reporting quarter, analysts expect the company to deliver $0.2 in earnings per share (EPS). That would represent a -20% year-over-year decrease. Revenue for the same period is expected to arrive at $887.6M.

Earnings Roundup: In the last fiscal quarter alone, Platform Specialty Products Corporation generated around $824M in revenue and net income of $0.11/share. That compares with the consensus estimate $799.64M and $0.1/share, respectively. For the prior quarter revenue for the company hit $735.1M, with earnings at $0.18/share.

Analyst Coverage: BofA/Merrill has been a brokerage house following shares of Platform Specialty Products Corporation (PAH), so its rating change is noteworthy. The stock was initiated at Buy, wrote analysts at BofA/Merrill, in a note issued to clients on Wednesday March 09, 2016. There was another key note issued by Sun Trust Rbsn Humphrey on Tuesday October 13, 2015. The firm launched coverage on PAH at Neutral.

Price Momentum: Despite the 2.77% increase in value, the stock’s new closing price represents a -62.06% fall in value from company’s one year high of $28.16. The stock is currently holding below its 50 day moving average of $15.58 and above its 200 day moving average of $9.64. Over the last three months and over the last six months, the shares of Platform Specialty Products Corporation (PAH), have changed -1.3% and 9.29%, respectively.

Current HollyFrontier Corporation (NYSE:HFC) PT Means Stock Is Worth Almost $55

HollyFrontier Corporation (HFC) up 2.88 per cent in the past week, is under coverage of 18 analysts who collectively recommend a hold rating on stock. 6 of the analysts have a buy or better rating; the 1 sells versus 1 underperforms. The 14 equity analysts who rate the stock have an average target price at $38.64, with individual targets ranging between $24 and $55. The shares closed last trade at $27.53, implying that analysts see shares rising about 40.36 per cent in 12 months’ time.

Insider Activity: Insiders look pessimistic about the prospects of the company that they seem to offload shares while they are -29.48 down so far this year. A Executive Chairman at HollyFrontier Corporation (HFC) sold shares in the company in a transaction completed on Tuesday March 29, 2016. Jennings Michael offloaded 35,000 shares in the company at an average price of $35.53 and ended up generating $1,243,550 in proceeds. Jennings Michael retains 177,169 shares in the company after this transaction. A Executive Chairman in the company, Jennings Michael, on Friday February 26, 2016 collected $3,360,000 from the sale of 100,000 shares at $35.53 each. Insiders are expected to know better about the health and prospects of their company, which is why insiders’ move deserves attention.

Earnings to Watch: Investors considering HFC stock at the going market price of $27.53/share should know the stock will next release quarterly results for the June 2016 quarter. For the reporting quarter, analysts expect the company to deliver $0.79 in earnings per share (EPS). That would represent a -45.52% year-over-year decrease. Revenue for the same period is expected to arrive at $2.5B.

Earnings Roundup: In the last fiscal quarter alone, HollyFrontier Corporation generated around $2.02B in revenue and net income of -$0.06/share. That compares with the consensus estimate $1.99B and $0.07/share, respectively. For the prior quarter revenue for the company hit $2.94B, with earnings at $0.24/share.

Analyst Coverage: Scotia Howard Weil has been a brokerage house following shares of HollyFrontier Corporation (HFC), so its rating change is noteworthy. The stock was upgraded to Sector Outperform from Sector Perform, wrote analysts at Scotia Howard Weil, in a note issued to clients on Wednesday May 18, 2016. There was another key note issued by Tudor Pickering on Monday May 16, 2016. The firm lowered its rating on HFC from Hold to Sell.

Price Momentum: Despite the 1.55% increase in value, the stock’s new closing price represents a -47.9% fall in value from company’s one year high of $54.73. The stock is currently holding above its 50 day moving average of $-13.03 and below its 200 day moving average of $30.55. Over the last three months and over the last six months, the shares of HollyFrontier Corporation (HFC), have changed -29.28% and 35.52%, respectively.